ADV: Free Depression Resources for You and Your Loved Ones

From: Chicago Research Center To: prentice654.allsms@blogger.com	To ensure that you continue receiving our emails, please add us to your address book or safe-sender list.

Who We Are: Established in 2005, Chicago Research Center is a trusted independent clinical research site dedicated to the advancement of medicine and treatments. We specialize in phase I-IV clinical trials for the pharmaceutical and biotechnology industries in sleep, general medicine, pain, memory, and mood disorders. CRC is proud to have contributed to the approval by the Federal Drug Administration (FDA) of more than 30 medications. Our Story Some of Our Exciting New Studies Include: KETAMINE TREATMENT Esketmaine is a rapid acting FDA-approved antidepressant that is dosed on a weekly basis via nasal spray. Unlike any other antidepressant on the market, this medication has been found to increase neural plasticity, which aids in longer-lasting antidepressant effects. Designed specifically for treatment-resistant depression. NOVEL ANTIDEPRESSANT Zuranolone is a short-term, as-needed antidepressant medication. It was initially designed for postpartum depression, and has subsequently been investigated for treatment of insomnia and major depressive disorder. Zuranolone is only taken for a period of 2-weeks at a time, with antidepressant effects typically becoming noticable within the first week.  DIGITAL STUDY This study is looking at the use of a new smartphone app, designed to help guide participants through cognitive behavioral therapy (CBT), and cognitive training. Completely remote study that can be done from the comfort of your own home! And many more! Check out our website for a full list of active clinical trials. Participate Qualified and enrolled participants may be compensated up to $2,250 for time and travel. Free transportation assistance is often made available for in-person studies. Testimonials |  Current Studies |  How It Works |  Apply to Participate © Copyright 2021. Chicago Research Center, Inc. 3401 N. Central Ave. Chicago, IL 60634 (773)282-9845 To view our privacy policy, click here. This message was sent by Chicago Research Center, 3401 N. Central Ave. , Chicago, IL, 60634, USA To contact the sender, reply to this email. This message may be a newsletter, solicitation or advertisement. Your request to unsubscribe or block will be enforced immediately. Change Profile | Unsubscribe | Block Sender | Report Abuse | Privacy Policy